Cargando…

Osteoporosis in Rheumatic Diseases

Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adami, Giovanni, Fassio, Angelo, Rossini, Maurizio, Caimmi, Cristian, Giollo, Alessandro, Orsolini, Giovanni, Viapiana, Ombretta, Gatti, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928928/ https://www.ncbi.nlm.nih.gov/pubmed/31766755 http://dx.doi.org/10.3390/ijms20235867

Ejemplares similares

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
por: Rotta, Denise, et al.
Publicado: (2020)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
por: Cioffi, Giovanni, et al.
Publicado: (2021)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
por: Bertoldo, Eugenia, et al.
Publicado: (2021)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2020)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
por: Fassio, Angelo, et al.
Publicado: (2022)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides
por: Adami, Giovanni, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Acute Phase Reaction and Fracture Risk Reduction: Are Gamma‐Delta T Cells and Hypovitaminosis D the Missing Link?
por: Adami, Giovanni, et al.
Publicado: (2022)

Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment
por: Fassio, Angelo, et al.
Publicado: (2020)

Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Changes in bone turnover markers and bone modulators during abatacept treatment
por: Adami, Giovanni, et al.
Publicado: (2023)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
por: Bixio, Riccardo, et al.
Publicado: (2022)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
por: Adami, Giovanni, et al.
Publicado: (2023)

Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
por: Fassio, Angelo, et al.
Publicado: (2022)

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013)

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2021)

Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system – An overlooked association?
por: Giollo, Alessandro, et al.
Publicado: (2020)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study
por: Adami, G., et al.
Publicado: (2021)

Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013)

Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study
por: Giollo, Alessandro, et al.
Publicado: (2022)

Gender disparity in authorship of guidelines and recommendations in rheumatology
por: Adami, Giovanni, et al.
Publicado: (2020)

The Use of Oral Amino‐Bisphosphonates and Coronavirus Disease 2019 (COVID‐19) Outcomes
por: Degli Esposti, Luca, et al.
Publicado: (2021)

Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
por: Adami, Giovanni, et al.
Publicado: (2021)

Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer
por: Dalbeni, Andrea, et al.
Publicado: (2018)

Patients with osteoporosis: children of a lesser god
por: Adami, Giovanni, et al.
Publicado: (2023)

Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)
por: Bertoldo, Francesco, et al.
Publicado: (2022)

Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
por: Chiodini, Iacopo, et al.
Publicado: (2021)

Glucocorticoid‐induced osteoporosis in rheumatic diseases
por: Pereira, Rosa Maria Rodrigues, et al.
Publicado: (2010)

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options
por: Bixio, Riccardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ocd96b9qbtt8clh9cpfkcd6gmq